Hemostemix

Hemostemix

Hemostemix

Hemostemix is a public clinical-stage company that develops innovative blood-derived cell therapies for medical conditions not yet adequately addressed.
Suggest edits
Founded
2006
Raised
$4.4M
Follow us
Companies in the same industry
Alexa global traffic share
Twitter followers
Terms of Service Privacy Policy Cookie Statement API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2020
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 1

Add info
Latest funding
$4,400,000
Debt financing - 2017
Wood Capital
Team Size
2
Employees
I work here
Location
Canada
Headquarters
Explore Canada
$4,400,000 Debt financing
PE HUB

Hemostemix nets $4.4 mln in debt funding, aims for $8 mln more

Stock markets Legal Privacy
Hemostemix
Hemostemix